Preclinical and clinical evaluation of an antibody therapeutic targeting prostate carcinoma

  • Lackmann, Martin, (Primary Chief Investigator (PCI))
  • Boyd, Andrew (Chief Investigator (CI))
  • Scott, Andrew (Chief Investigator (CI))

Project: Research

StatusFinished
Effective start/end date1/04/0831/03/11

Funding

  • Cancer Australia: AUD294,657.86
  • Prostate Cancer Foundation of Australia: AUD362,454.59